Skip to main content
Erschienen in: Journal of Gastroenterology 11/2009

01.11.2009 | Original Article—Alimentary Tract

Coping strategy when patients with quiescent Crohn’s disease recognize that their conditions are worsening

verfasst von: Makoto Tanaka, Yasushi Iwao, Susumu Okamoto, Haruhiko Ogata, Toshifumi Hibi, Keiko Kazuma

Erschienen in: Journal of Gastroenterology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Although self-management is important for Crohn’s disease (CD), there is no research focusing on self-management, especially in worsening conditions. The purpose of this study was to investigate how quiescent CD patients cope with their conditions worsening.

Methods

A questionnaire containing six types of coping strategy for worsening conditions was created based on a semi-structured interview. Seventy-six quiescent CD patients participated in this study. We also analyzed the related factors of each coping strategy for worsening conditions.

Results

The total percentage of subjects who adopt the strategy of “change contents of meals” ‘always’ or ‘often’ was approximately 70%. On the other hand, the strategy of “see a doctor immediately” was approximately 20% in total of ‘always’ or ‘often’. When ‘sometimes’ was added, “take extra medicine” was approximately 42%. The subjects with experience of hospitalization within 3 years (Z = −2.352, P = 0.019), presence of supplemental elemental diet (Z = −5.182, P < 0.001), or 1 year or less interval since last relapse (Z = −3.352, P = 0.001) showed a significant tendency to adopt the coping strategy of “take (add to) elemental diet.”

Conclusion

The major coping strategy was “change contents of meals,” and the minor coping strategy was “see a doctor immediately.” The subjects with unstable disease state adopted the coping strategy of “take (add to) elemental diet.” The coping strategies for worsening conditions vary according to patients’ backgrounds. The coping type should be taken into account when treating CD patients.
Literatur
1.
Zurück zum Zitat Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306–10.CrossRefPubMed Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol. 1988;10:306–10.CrossRefPubMed
2.
Zurück zum Zitat Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–86.CrossRefPubMed Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–86.CrossRefPubMed
3.
Zurück zum Zitat Joachim G, Milne B. Inflammatory bowel disease: effects on lifestyle. J Adv Nurs. 1987;12:483–7.CrossRefPubMed Joachim G, Milne B. Inflammatory bowel disease: effects on lifestyle. J Adv Nurs. 1987;12:483–7.CrossRefPubMed
4.
Zurück zum Zitat Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822–30.CrossRefPubMed Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822–30.CrossRefPubMed
5.
Zurück zum Zitat Mussell M, Bocker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1273–80.CrossRefPubMed Mussell M, Bocker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:1273–80.CrossRefPubMed
6.
Zurück zum Zitat Irvine EJ. Review article: patients’ fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):54–9.CrossRefPubMed Irvine EJ. Review article: patients’ fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):54–9.CrossRefPubMed
7.
Zurück zum Zitat Kennedy AP, Rogers AE. Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guidebook for ulcerative colitis. Patient Educ Couns. 2002;47:257–63.CrossRefPubMed Kennedy AP, Rogers AE. Improving patient involvement in chronic disease management: the views of patients, GPs and specialists on a guidebook for ulcerative colitis. Patient Educ Couns. 2002;47:257–63.CrossRefPubMed
8.
Zurück zum Zitat Hashimoto H, Iwao Y, Hibi T, Ueno F, Miyahara T, Sugita A, et al. A model of quality of life in the patients with Crohn’s disease (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (JJSG). 1999;96:1258–65. Hashimoto H, Iwao Y, Hibi T, Ueno F, Miyahara T, Sugita A, et al. A model of quality of life in the patients with Crohn’s disease (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (JJSG). 1999;96:1258–65.
9.
Zurück zum Zitat Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.PubMed Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.PubMed
10.
Zurück zum Zitat Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741–5.PubMed Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741–5.PubMed
11.
Zurück zum Zitat Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;1. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2009;1.
12.
Zurück zum Zitat Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology. 1995;108:1056–67.CrossRefPubMed Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology. 1995;108:1056–67.CrossRefPubMed
13.
Zurück zum Zitat Tanaka M, Iwao Y, Sasaki S, Okamoto S, Ogata H, Hibi T, et al. Moderate dietary temperance effectively prevents relapse of Crohn Disease: a prospective study of patients in remission. Gastroenterol Nurs. 2007;30:202–10.CrossRefPubMed Tanaka M, Iwao Y, Sasaki S, Okamoto S, Ogata H, Hibi T, et al. Moderate dietary temperance effectively prevents relapse of Crohn Disease: a prospective study of patients in remission. Gastroenterol Nurs. 2007;30:202–10.CrossRefPubMed
14.
Zurück zum Zitat Bernal I, Domenech E, Garcia-Planella E, Marin L, Manosa M, Navarro M, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2006;51:2165–9.CrossRefPubMed Bernal I, Domenech E, Garcia-Planella E, Marin L, Manosa M, Navarro M, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2006;51:2165–9.CrossRefPubMed
15.
Zurück zum Zitat Robinson A, Thompson DG, Wilkin D, Roberts C, Northwest Gastrointestinal Research. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet. 2001;358:976–81.CrossRefPubMed Robinson A, Thompson DG, Wilkin D, Roberts C, Northwest Gastrointestinal Research. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet. 2001;358:976–81.CrossRefPubMed
16.
Zurück zum Zitat Travis SPL, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55(Suppl 1):i16–35.CrossRefPubMed Travis SPL, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: current management. Gut. 2006;55(Suppl 1):i16–35.CrossRefPubMed
Metadaten
Titel
Coping strategy when patients with quiescent Crohn’s disease recognize that their conditions are worsening
verfasst von
Makoto Tanaka
Yasushi Iwao
Susumu Okamoto
Haruhiko Ogata
Toshifumi Hibi
Keiko Kazuma
Publikationsdatum
01.11.2009
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 11/2009
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0104-0

Weitere Artikel der Ausgabe 11/2009

Journal of Gastroenterology 11/2009 Zur Ausgabe

Original Article—Liver, Pancreas, and Biliary Tract

Decreased production of immunoglobulin M and A in autoimmune pancreatitis

Original Article—Alimentary Tract

Sonic hedgehog relates to colorectal carcinogenesis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.